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interconnected. This article reviews key elements from the national to the individual level that contribute to the success of the
implementation of IPC measures and gives perspectives for improvement. Governance approaches, modes of communication and formats
of guidelines are discussed with a view to improve collaboration and transparency among actors. The culture of IPC inﬂuences practices
and varies according to countries, specialties and healthcare providers. We describe important contextual aspects, such as relationships
between actors and resources and behavioural features including professional background or experience. Behaviour change techniques
providing goal-setting, feedback and action planning have proved effective in mobilizing participants and may be key to trigger social
movements of implementation. The leadership of international societies in coordinating actions at international, national and institutional
levels using multidisciplinary approaches and fostering collaboration among clinical microbiology, infectious diseases and IPC will be
essential for success.
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E-mail: gbirgand@gmail.comIntroductionScientiﬁc knowledge on infection prevention and control (IPC)
has increased during the last decade and led to the publication
of many IPC recommendations and guidelines at national, Eu-
ropean and international levels. Despite such guidance,
healthcare-associated infections (HCAI) still remain a major
public health concern [1].Clinical Microbiology and Infection © 2015 European Society of CThere are many barriers to surmount before printed
evidence-based clinical guidance translates into improvement
in the quality of patient care. A recent Cochrane review
found that when used alone, printed educational materials
generally led to only modest improvements in professional
practice [2]. Coercive implementation of recommendations
using regulatory approaches assumes that the behaviour of
healthcare professionals (HCP) will be congruent with rec-
ommendations. However, this is rarely the case in practice
[3]. The regulatory approach has improved IPC practices, but
rapidly reached its limits and several unintended effects have
been revealed [4].
Implementation of and compliance with recommendations
varies among European countries, hospitals and wards [1].
Wide variation is observed both with regard to process in-
dicators, such as appropriate perioperative antimicrobialClin Microbiol Infect 2015; 21: 1067–1071
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methicillin-resistant Staphylococcus aureus [5,6].
Five factors contribute to the implementation of health
service innovations: intervention characteristics (e.g. evidence
strength and quality), outer setting (e.g. patient needs and re-
sources), inner setting (e.g. culture, leadership engagement),
characteristics of the individuals involved, and the process of
implementation (e.g. plan, evaluate and reﬂect) [7].
The social, cultural and organizational factors that might
affect behaviour are rarely taken into account for translation of
strategies into practice [8]. This may well be one of the reasons
why it remains a challenge to optimize IPC.
Reasons for successful or unsuccessful implementation of
guidelines are often multiple and interconnected. They may be
found in the guidelines themselves, in the implementation
process, or in local organizational determinants.
In this article we focus on determinants about the imple-
mentation of IPC guidelines, and analyse and discuss relevant
aspects. We review the principles of governance, surveillance
and communication at the national level, and cultural, organi-
zational and individual aspects at the local level.Key Determinants of IPC Implementation at
the National LevelShaping guidelines and recommendations
Dozens of guidelines related to IPC are now available to HCP.
As an example, we identiﬁed 15 international guidelines, pro-
duced by various international groups and countries from 2003
to 2014, to prevent transmission of multidrug-resistant organ-
isms in health care [9,10]. These documents often contain dif-
ferences that create confusion about what exactly should be
implemented for controlling multidrug-resistant organisms.
One major issue is that most recommendations usually pre-
sent the level and strength of evidence rather than ranking the
relative importance of preventive measures. Therefore, IPC and
HCPs meet difﬁculties when prioritizing, more particularly for
measures not connected with high-quality evidence but still likely
to be critical for an effective preventive strategy (e.g. wearing
operating masks in surgery). To overcome these difﬁculties, the
Society of Hospital Epidemiology of America compendium
recently proposed two levels of recommendations, i.e. basic
practices to be adopted in all healthcare facilities and special
approaches to be considered if basic practices fail to be effective
[11]. Moreover, the European Committee on Infection Control
was created under the aegis of the ESCMID to develop tools and
guidelines with practical relevance. The use of behavioural bun-
dles can also help to prioritize what is most important [12].Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectAdjust governance approaches
Different governance approaches have implicitly or explicitly
been adopted for IPC. The traditional way of governance is
hierarchical. Regional committees coordinated by national
health authorities have been effective, for example, in con-
trolling methicillin-resistant Staphylococcus aureus, Clostridium
difﬁcile or resistant Enterobacteriaceae in several European
countries [13–15]. Regardless of where the initiatives begin,
coordination and collaboration are needed between the na-
tional and facility levels.
When there are several levels of healthcare initiative in large
countries, such as national, federal or regional levels, e.g. USA,
Italy or Germany, there may be more challenges in imple-
menting coordinated actions. New mechanisms of governance
have been designed to avoid mistrust or fearfulness, to
decentralize actions and cope with the increased complexity of
society [16]. In modern IPC governance, partnerships are
promoted and participation of HCPs and patients is encour-
aged, with the purpose of democratizing decision-making and
fostering accountability through mutual collaboration [17]. In
such multi-stakeholder governance, leaders should help HCPs
and patients to create and achieve shared goals, mixing regu-
lation and persuasion.
Accurate use of surveillance systems and indicators
National surveillance networks are critical to offer tools for the
surveillance of HCAI and process indicators. Based on the
principle that HCAI surveillance should form the cornerstone
of IPC, these networks are necessary for helping to implement
guidelines at the local level and reduce HCAI rates [18]. The
role in prevention of feedback of HCAI rates for benchmark or
the local use of HCAI rates over time is unknown. However,
surveillance per se allows the start of a collaborative effort
between IPC personnel and clinical staff for prevention and
implementing recommendations.
Reporting HCAI quality indicators against benchmarks cre-
ates motivation and competition but it is not clear to what
extent it adds to implementation success [19]. Gaming due to
variable interpretation of deﬁnitions and diagnostics to bring
down rates and improve outcomes measures, particularly when
penalties are attributed, may be the result of a strategy based on
public reporting of HCAI.
Communication and new technology
Many modes of communication (e.g. websites, social media,
games, think-tanks…) have emerged in recent decades to in-
crease HCP and patient knowledge and empower them in the
quality of care processes. Addressing health literacy constitutes
a necessary skill for patient involvement [20]. Patients have
rapidly adopted these supports, which have become essential inious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1067–1071
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health authorities have created e-governance to deliver
healthcare services using high-speed transfer of information and
data, and to increase transparency and measure public satis-
faction. Transparency is important to build trust and obtain the
users’ collaboration. The use of the social web may empower
people and facilitate multi-way communications and engage-
ments between and among government agencies, patients and
HCPs [21].
New technologies to monitor practices by automated sur-
veillance systems have also been developed. The use of tech-
nical facilitators may help HCPs to comply with
recommendations, especially if they provide comfort and are
simple to adopt [22]. Outcomes might however be mitigated
depending on the technology, the data interpretation and the
feedback mechanism [23].Key Determinants of IPC Implementation at
the Institutional LevelIn the national context
The variation in HCAI rates across countries, hospitals and
specialties underscores the potential inﬂuence of the culture on
IPC [24]. People hold different ideas about health, causes of
disease, labelling of illness, prevention and treatment modalities.
These ideas shape both the expectations and the behaviour of
professionals in hospitals. Such ideas are further shaped and
reinforced through local (organizational) culture, e.g. within
specialties or healthcare provider organizations.
Based on a model of cultural dimensions of a society, it was
suggested that two of the six Hofstede’s cultural dimensions, i.e.
power distance and uncertainty avoidance were critical for IPC
behaviour [25]. Concepts of ‘uncertainty avoidance’ (i.e. un-
willingness to accept uncertainty and risks) and ‘power distance’
(i.e. willingness to accept that power is unevenly distributed)
have been described as the reasons for cultural inﬂuences.
Scores measuring these two dimensions were correlated with a
high level of methicillin-resistant Staphylococcus aureus across
European countries [26] and unjustiﬁed antibiotic prophylaxis
[25]. Although correlation does not imply causality, it is
believed that countries with low power distance and low un-
certainty avoidance scores exhibit better risk management for
prevention.
An intervention successful in one country may fail in another
if local organizational factors and behaviour-speciﬁc de-
terminants are not considered [27]. Irrespective of country, a
positive local organizational culture is likely to be a key
component for any successful IPC programme [28].Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology anIn the institutional context
Organizational obstacles may inﬂuence IPC implementation.
Many different hospital disciplines are typically involved in IPC,
making collaboration, coordination, communication, teamwork
and efﬁcient care logistics essential. Fragmentation of practice
may lead to diluted responsibilities and reduced patient safety
[29]. Social inﬂuence and the networks through which it
operates, the encouragement or inhibition from the organiza-
tion, the messy, stop–start and difﬁcult-to-research process of
assimilation and routinization predict the successful adoption of
innovation [30].
Leadership has been repeatedly identiﬁed as a core
component of successful multimodal strategies [31]. Delegated
leadership encourages ownership and is perceived favourably
by frontline HCPs. Senior frontline leadership providing re-
sources and reinforcement is often considered important in
day-to-day duties. This mix of top–down and devolved ap-
proaches seems key for changes in IPC implementation [16].
There is a well-established discourse on the potential role
and beneﬁts of involving patients in shaping healthcare service
design and delivery through consultation, followed by feedback
and evaluation to improve services [32]. Patients may have a
potentially important role in promoting good IPC and in eval-
uating performance. Moreover, involvement of patients in
decision-making around their own individual treatment plans
can result in enhanced self-management, and better health
outcomes [33]. However, HCPs may view involvement of pa-
tients in IPC practices as unrealistic [34].
Resources is another important element for successful
implementation of IPC. In an era of ﬁnancial constraints, bud-
gets devoted to direct patient care can be preferred to pre-
vention. Critical resources include materials, stafﬁng levels and
structural resources (single room beds) [1].In the individual context
The professional background or experience of HCPs can in-
ﬂuence IPC-practice beliefs [35]. Many characteristics of indi-
vidual professionals might inﬂuence the decision to implement
guidelines, creating differences in behaviour [36]. Disagreement
with guidelines or with speciﬁc recommendations, a lack of
outcome expectancy, a lack of self-efﬁcacy expectations, and a
lack of motivation might all lead to suboptimal patient safety.
Education and training represent an important component
for accurate implementation of recommendations. However,
they should be used as part of a multimodal intervention and be
task oriented, with emphasis on bedside-teaching and
simulation-based training [28].
Moreover, the recipient of IPC measures is an HCP whose
main professional activity is not devoted to IPC, e.g. surgicald Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1067–1071
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perceived as secondary to the HCP’s main professional activity.
Principles of behavioural and social science and commercial
marketing have been used to persuade a target group to adopt
behaviours that are beneﬁcial to health. The social Marketing
approach has been extensively used to change public health
behaviours (e.g. to promote non-smoking) and has recently
gained ground within IPC [37].
Behaviour-change techniques have been successful in several
IPC ﬁelds by providing goal-setting, feedback and action plan-
ning. A ﬁrst example is interventions to improve hand hygiene,
with the use of ‘actionable feedback’ [38]. This model empha-
sizes that feedback should be timely, individualized, non-
punitive and customized. A second example of quality
improvement through actionable feedback is the Michigan
Keystone Project, which achieved signiﬁcant reduction in
central-line-associated bloodstream infections and ventilator-
associated pneumoniae; the study established a comprehen-
sive safety programme [39]. Behavioural factors were also
identiﬁed, contributing to the success of the intervention [27].
The use of a checklist to remind participants about the care
bundle elements may have stimulated a culture change,
increasing safety as a priority for the participating clinical teams.
Interestingly, the same design implemented in the UK gave
unsuccessful results in most participating intensive care units
[27]. This experience underlines the requirement to mobilize
participants in a social movement of implementation by devel-
oping the sense of ownership and community around the
innovation.ConclusionInternational guidelines may facilitate instituting quality stan-
dards across all countries. Local determinants and cultural di-
mensions, however, will have a profound inﬂuence on
implementation and must be carefully considered when adapt-
ing recommendations. Leadership and coordinated actions at
national and facility levels using multidisciplinary approaches will
be essential for success. The passive presence of written
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